symbol,statement_type,period_end,line_item,value
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-416708000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-440966000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,745268000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,380903000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-1233798000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,End Cash Position,413991000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,360395000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,53596000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,470793000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-173529000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-33861000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,380903000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,380903000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,304302000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,108030000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Payments,
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Issuance,108030000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,196272000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,-440966000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,637238000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-1234287000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,-2718000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,1669000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,0.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,0.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-1233238000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,560000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-1233798000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,817090000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-198334000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-430782000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,61823000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,46435000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-374061000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Prepaid Assets,15339000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-510313000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,329995000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,173704000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,343373000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Depreciation,343373000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Pension And Employee Benefit Expense,-3794000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-205000.0
SMSPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,923375000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,-20353000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-377636000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,652934000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,284778000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-521600000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,End Cash Position,360395000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,73078000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,287317000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,306790000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-217516000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-25396000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,284778000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,284778000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,275298000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,202071000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Payments,
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Issuance,202071000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,73227000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-377636000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,450863000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-520720000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,-1587000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,1587000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,0.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,0.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-520720000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,880000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-521600000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,501247000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-154000000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-545478000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,41744000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-88509000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Payable,438677000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Prepaid Assets,43064000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-101984000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-878470000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,224657000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,315157000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,9116000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Depreciation,315157000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Pension And Employee Benefit Expense,-2033000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-373000.0
SMSPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,661068000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-74707000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-430579000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,352908000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,0.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-299207000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,End Cash Position,73778000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,700000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,465828000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-392750000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-319689000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-209276000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-25396000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,0.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,0.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,-77671000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,258771000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Payments,0.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Issuance,258771000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,-336442000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-430579000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,94137000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-297561000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,-888000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,1581000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-1680000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-1680000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-296574000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,2633000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-299207000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,224500000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-46000000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-312894000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,-43134000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,-4752000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Payable,424373000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Prepaid Assets,32907000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,275981000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-998269000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,209514000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,321254000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,7087000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Depreciation,314167000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Pension And Employee Benefit Expense,-3414000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,544000.0
SMSPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,53491000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,178123000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-366713000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,460788000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-272474000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,End Cash Position,465828000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,404231000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,61597000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-117470000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,-1000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-177062000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-25395000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,94075000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,-29464000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Payments,-38353000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Issuance,8889000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,123539000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-328360000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,451899000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-271530000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,-1983000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,2756000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,0.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,0.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-272303000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,171000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-272474000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,450597000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-149204000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-583754000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,-39952000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-41897000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Payable,74176000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Prepaid Assets,-14584000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-1133102000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,571605000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,175918000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,0.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,321525000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,7100000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Depreciation,314425000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Pension And Employee Benefit Expense,-415000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-20000.0
SMSPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,684991000.0
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,1000.0
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Payments,-20223000.0
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Issuance,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Prepaid Assets,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,784000.0
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,4337000.0
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Depreciation,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Pension And Employee Benefit Expense,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
SMSPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
